Tsutomu Takeuchi
Papers
1
Total Citations
44
H-Index
1
About
Tsutomu Takeuchi is a pioneering figure in parasitology and drug discovery, whose research has centered on the molecular mechanisms and therapeutic vulnerabilities of protozoan parasites, particularly *Toxoplasma gondii*. His major contribution lies in the identification of small-molecule inhibitors targeting the parasite’s nucleoside triphosphate hydrolase (NTPase), a novel enzyme critical to the tachyzoite stage. In a landmark 2002 study, Takeuchi and his team screened approximately 150,000 compounds using a robotic assay, uncovering five distinct inhibitor species that effectively block NTPase activity. This work, which has garnered 44 citations, represents a foundational step toward developing targeted chemotherapies against toxoplasmosis, a disease with significant global health impact. Beyond this key achievement, Takeuchi’s broader efforts have advanced the understanding of parasite biochemistry and high-throughput screening methodologies. His research continues to inspire new avenues for antiparasitic drug development, demonstrating how molecular-level insights can translate into practical therapeutic strategies. For students and researchers, Takeuchi’s career exemplifies the power of combining innovative screening technologies with deep biological knowledge to address neglected infectious diseases.
Research Focus
Key Achievements
Top Papers
- 1